Cellular Biomedicine Group Other Current Assets

Cellular Biomedicine Group (CBMG) currently reports a other current assets of $1.5M as of September 2020. That compares with $19M in the prior-year period — down 91.9% year over year. Use the charts on this page to explore Cellular Biomedicine Group's other current assets history and peer comparisons.

Cellular Biomedicine Group's other current assets decreased from $19M to $1.5M — a 91.9% year-over-year decrease (period ending September 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Cellular Biomedicine Group reported $1.5M in other current assets as of September 2020. That compares with $19M in the prior-year period — down 91.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current assets of $1.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Cellular Biomedicine Group, and consider following CBMG for alerts when major investors trade the stock.

Cellular Biomedicine Group is classified in the Healthcare sector. On other current assets, it currently shows $1.5M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CBMG with unrelated industries.